A new UCLA Health study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are most vulnerable in Huntington’s disease and triggering downstream pathologies and motor impairment, shedding light on disease mechanisms and potential new ways to develop therapies.
Johnson & Johnson’s Q2 2024 net earnings drop 12.8% to $4.6bn
In the US, the reported sales of Johnson & Johnson surged by 7.8% to $12.5bn compared to $11.6bn in Q2 2023. Credit: josefkubes / Shutterstock.
July 18, 2024